Some medical weight loss plans may include semaglutide or tirzepatide depending on candidacy, availability, goals, and provider recommendation
By integrating advanced medical treatments with a holistic approach, we address not only weight management but also overall well-being, considering factors such as nutrition, physical activity, and emotional health
Retatrutide achieved 82% liver fat reduction in Phase 2a trials, far exceeding what tirzepatide or semaglutide achieve
To address this limitation, we apply an interdependence-aware attribution framework grounded in FAIR principles (Fairness, Attribution, Inference, Reproducibility) to decompose a fixed observed outcome into drug-attributable and context-attributable components